期刊文献+

糖尿病心血管自主神经病变的诊治进展 被引量:1

下载PDF
导出
摘要 在世界范围内,随着人们静坐的生活方式、人口老龄化及肥胖,使得2型糖尿病的发病率迅速增加。糖尿病可引起多种急慢性并发症,糖尿病心血管自主神经病变(CAN)是一种因长期高血糖使得心脏交感神经传出支发生病变引起心律异常、血管舒缩功能异常的严重的、常见的糖尿病慢性并发症,主要表现为体位性低血压、静息时心动过速和无症状性心肌缺血。无糖尿病的心血管事件多发生在晨起时,糖尿病心血管事件在清晨并未增加,而是在一天的时间内相对均匀分布,CAN与糖尿病病情严重程度关系密切,控制不良者居多,患病率随年龄的增长而上升,以50-60岁居多,我国以2型糖尿病患者占绝大多数,大都起病缓慢,有的早期无明显症状,临床表现较复杂,缺乏特异性,易被糖尿病其他相关并发症、并存症所掩盖。一旦发生多不可逆,严重影响患者预后。本文主要介绍CAN的诊断及治疗方面的研究进展。
出处 《心血管病防治知识(学术版)》 2014年第4期156-158,共3页 Prevention and Treatment of Cardiovascular Disease
  • 相关文献

参考文献13

  • 1Pfeifer M A, Cook D, Brodsky J, et al. Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man [J]. Diabetes, 1982, 31(4): 339-345.
  • 2Sandroni P, Benarroeh E E, Low P A. Pharmacological dissection of components of the Valsalva maneuver in adrenergic failure [J]. Journal of Applied Physiology, 1991, 71(4): 1563-1567.
  • 3Vinik, Aaron I., and Dan Ziegler. "Diabetic cardiovascular autonomic neuropathy."?Circulation? 115.3 (2007): 387-397.
  • 4Montano N, Ruscone T G, Porta A, et al. Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt [J]. Circulation, 1994, 90 (4): 1826-1831.
  • 5La Rovere M T, Bigger Jr J T, Marcus F I, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators [J]. Lancet, 1998, 351(9101): 478--484.
  • 6Gaseh J, Reimann M, Reichmann H, et al. Determination of baroreflex sensitivity during the modified Oxford maneuver by trigonometric regressive spectral analysis [J]. PIoS one, 2011, 6(3): e18061.
  • 7Hamner J W, Taylor J A. Automated quantification of sympathetic beat-by-beat activity, independent of signal quality [J]. Journal of Applied Physiology, 2001, 91(3): 1199-1206.
  • 8Vinik A I, Maser R E, Mitchell B D, et al. Diabetic autonomic neumpathy[J]. Diabetes care, 2003, 26(5): 1553-1579.
  • 9Maser R E, Lenhard M J. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment[J]. Journal of Clinical Endocrinology & Metabolism, 2005, 90(10): 5896-5903.
  • 10Goto Y, Hotta N, Shigeta Y, et al. Effects of an aldose reductase inhibitor, epalrestat, on diabetic neuropathy. Clinical benefit and indication for the drug assessed from the results of a placebo-cantrolled double-blind study [J]. Biomedicine & pharmacotherapy, 1995, 49(6): 269-277.

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部